Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Офтальмология / Английские материалы / Evidence-based Ophthalmology_Wormald, Smeeth, Henshaw_2004.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
6.03 Mб
Скачать

34 Multifocal and monofocal intraocular lenses

Martin Leyland

Background

Current techniques of cataract surgery and IOL implantation allow accurate prediction of postoperative refraction such that there can now be a reasonable expectation of good uncorrected distance acuity. This has been driven partly by the change from cataract surgery using a large (10 mm) incision to small (3–4 mm) incision phacoemulsification surgery. Among other benefits, this change offers greater predictability of refractive outcomes, which is a necessary pre-requisite for good visual acuity without the need for glasses.1,2

Treatment options

Standard IOLs used have a fixed refractive power, so that the focal length is fixed (monofocal). This means that most patients will require a reading addition to their distance glasses.3 While the majority of people undergoing cataract surgery may be happy to use reading glasses, a proportion are likely to seek good unaided near vision as well as distance vision. The need for reading glasses for near vision is unlikely to be considered an important issue at present in developing countries, where the burden of blindness due to cataract is very high.

One approach to improve near visual acuity is to modify the IOL. An IOL may provide near and distance vision if both powers are present within the optical zone. This has been attempted using diffractive optics or with zones of differing refractive power. Both types of IOL divide light up to focus at two (bifocal) or more (multifocal) points, so that both near and distant objects may be focussed on the retina. Optical evaluation of multifocal IOLs indicates that a twoto threefold increase in the depth of field is achieved at the expense of a 50% reduction in the contrast of the retinal image.4

Question

Does the use of multifocal intraocular lenses offer benefits over the current standard treatment of monofocal intraocular lens implantation?

The evidence

A systematic review of randomised controlled trials of multifocal intraocular lenses was undertaken to determine whether their use offers benefits over the current standard treatment of monofocal intraocular lens implantation.5 Eight RCTs were identified for inclusion in the review,5–12 and the characteristics of these trials are summarised in Table 34.1.

Question

Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses for visual acuity (unaided and corrected)?

The evidence

Distance acuity was described in five trials as the proportion of participants achieving specified acuity levels (Figure 34.1). The proportion of participants achieving less than 6/6 unaided was not significantly different between multifocal and monofocal groups (Peto odds ratio 1·21, 95% CI 0·751·96). Three trials describe mean acuity rather than proportions (Figure 34.2). There was no evidence of any difference in acuity between multifocal and monofocal groups (standardised mean difference 0·03, 95% CI 0·24 0·18).

Similarly, there was no difference between IOL types with respect to the proportion of participants achieving less than 6/6 best corrected visual acuity in seven studies (Peto odds ratio 1·43, 95% CI 0·99–2·09, Figure 34.3). There was no difference in mean best-corrected acuity in the three refractive IOL trials that reported this outcome

(standardised mean difference 0·19, 95% CI 0·03–0·40, Figure 34.4).

Because of significant heterogeneity no meta-analysis was conducted on the data for near visual acuity. The six trials that reported this outcome found that near vision tended to improve with the use of a multifocal IOL (Figure 34.5).

259

 

Outcomes

Distanceacuity

 

Intervention

RigidPMMAIOLs:3Mdiffractive

monofocalintraocularlenses

Participants

SaudiArabia

comparingmultifocalto

Methodquality*

Jadadscore3

Characteristicsoftrials

Method

Randomised

Table34.1

Trial

El-Maghraby

Nearacuity

 

 

 

 

Distanceacuity

IOL(815LE)or3Mmonofocal

IOL(15LE)

Phacowithcan-opener

capsulotomy

 

RigidPMMAIOLs:Allergan

47%male

Meanage57years

Multifocalgroup:39

Monofocalgroup:38

Unilateral–felloweye notblind

USA

Allocationconcealment

adequate

 

 

 

Jadadscore5

Singlecentre

Maskingnotstated

Studyduration2to4months

 

 

Randomised

6

 

 

 

 

 

etal.,1992

 

 

 

 

Steinert

Nearacuity

Depthoffield

Contrastsensitivity

Glare

Spectacleuse

Non-validatedsubjective assessment

Distanceacuity

Nearacuity

Depthoffield

Contrastsensitivity

Spectacleuse

Non-validatedsubjective

outcome Adversephenomena

Distanceacuity

Nearacuity

Contrastsensitivity

Spectacleuse

Non-validatedsubjective

assessmentofvisual

qualityquestionnaire

Adversephenomena

Distanceacuity

Nearacuity

Contrastsensitivity

Spectacleuse

Non-validated

questionnaire

Adversephenomena

refractiveIOL(MPC25NB)or

AllerganmonofocalIOL

(PC25NB)

Phaco,capsulotomytypenot

specified

 

RigidPMMAIOLs:Allergan

refractiveIOL(MPC25)or

AllerganmonofocalIOL(PC25)

Myopicastigmatismmonofocal

group

ECCEwithcan-opener

capsulotomy

RigidPMMAIOLs:3Mdiffractive

IOL(unspecified)or3M

monofocalIOL(unspecified)

ECCE,capsulotomytypenot

specified

 

 

 

RigidPMMAIOLs:Pharmacia

diffractiveIOL(808X)or

PharmaciamonofocalIOL

(808D)

PhacoandECCE

Capsulotomynotspecified

 

42%male

Meanage72years

Multifocalgroup:32

Monofocalgroup:30

Unilateral–felloweye

phakic

UK

42%male

Meanage77years

Multifocalgroup:25

Monofocalgroup:25

Unilateral–felloweye

phakic,mostcataractous

Italy

41%male

Meanage71years

Multifocalgroup:38

Monofocalgroup:42

Unilateral–felloweye

phakicwithnosignificant

cataract

Europe

49%male

Meanage66years

Multifocalgroup:79

Monofocalgroup:70

Unilateral–statusof

felloweyenotreported

Allocationconcealment

adequate

 

 

 

 

Jadadscore2

Allocationconcealment

unclear

 

 

 

 

Jadadscore1

Allocationconcealment

unclear

 

 

 

 

 

Jadadscore1

Allocationconcealment

adequate

 

 

 

 

Multicentre

Double-masked

Studyduration3to6months

 

 

 

Randomised

Singlecentre

Maskingnotstated

Studyduration4to6months

 

 

 

Randomised

Singlecentre

Maskingnotstated

Studyduration12months

 

 

 

 

Randomised

Multicentre

Open/unmasked

Studyduration5to6months

 

 

 

etal.,

1992

 

 

 

 

Percival

8

 

 

 

 

 

Rossetti

9

 

 

 

 

 

 

Allenetal.,

1996

 

 

 

 

 

 

 

 

 

etal.,1993

 

 

 

 

 

etal.,1994

 

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

(Continued)

Outcomes

Intervention

Method quality* Participants

(Continued)

Method

Table34.1

Trial

USA, Germany and Austria Foldable 3-piece silicone optic, Distance acuity

Jadad score 5

Randomised

.,al etJavitt

Nearacuity

Validatedquestionnaire

(modifiedcataractTyPE)

Validatedqualityoflife

questionnaire

 

Distanceacuity

PMMAhapticIOLs:Allergan

refractiveIOL(SA40N)or

AllerganmonofocalIOL

(SI40NB)phacowithcontinuous

circularcapsulorhexis

 

DomilensasphericrefractiveIOL

44%male

Meanagenotgiven,50%

65–74years

Multifocalgroup:124

Monofocalgroup:111

Bilateralsurgery

India

Allocationconcealment

adequate

 

 

 

 

Jadadscore1

Multi-centre

Double-masked

Studyduration3to6months

 

 

 

Randomised

2000

 

 

 

 

 

Kamlesh

7

 

 

 

 

 

 

(Progress 3) or monofocal IOL Near acuity

Allocation concealment Gender not given

Single centre

.,al et

Depthoffield

Contrastsensitivity

Spectacleuse

Non-validatedsubjective

outcome

Adversephenomena

Distanceacuity

(Flex65)ECCEwithenvelope

capsulotomy Refractiveaimnotstated

 

 

 

Multifocal(refractive,2designs)

Meanage55·7yrs

(multifocal),53·5yrs

(monofocal)

Nonone-cataract

pathology

Astigmatismlessthan 1·5dioptres Unilateralsurgery

UK

unclear

Jadadscore5

Studyduration3months

Randomised

2001

Leyland

14

 

Double-masked trial of Allocation concealment Over 50 years of age or monofocal IOL implantation Near acuity

.,al et

Depthoffield

Contrastsensitivity

Spectacleuse

Validatedquestionnaire

(modifiedcataract

typeE)

Adversephenomena

 

 

Bilateralcataract Surgicalintervention:

Nonone-cataract Bilateralsmallincisionphacoand

pathology IOL,aimingforemmetropia

Lessthan1·5dioptres

astigmatism

Bilateralsurgery

 

with5pointsindicatingthebestmethodology.

ECCE,extracapsularcataractextraction

2002

intraocularmonofocallenses

 

 

 

 

 

scoredwasquality*Methodologicalfrom0to5(Jadad,1996)

lens;intraocularIOL,Abbreviations:PMMA,polymethylmethacrylate;

 

 

 

 

 

 

 

,

 

 

 

 

 

 

 

 

13

 

adequate

 

 

 

 

 

 

 

 

bilateralmultifocal,bifocal,or

 

 

 

 

 

 

 

 

12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Evidence-based Ophthalmology

 

 

 

 

 

 

 

 

Study

Multifocal

Monofocal

 

Peto OR

 

Weight

Peto OR

or sub-category

n/N

n/N

 

95% CI

 

%

95% CI

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

Steinert et al., 199210

26/32

22/30

 

 

 

 

 

16·74

1·56 (0·48, 5·09)

Leyland et al., 200212

7/45

3/16

 

 

 

 

 

10·01

0·80 (0·17, 3·67)

Subtotal (95% CI)

33/77

25/46

 

 

 

 

 

26·75

1·21 (0·48, 3·09)

Test for heterogeneity: chi square = 0·47, df = 1 (P = 0·49)

 

 

 

 

 

 

 

Test for overall effect: Z = 0·40 (P = 0·69)

 

 

 

 

 

 

 

 

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

EI-Magrahby et al., 19926

22/28

21/33

 

 

 

 

 

19·49

2·03 (0·68, 6·06)

Rossetti et al., 19949

35/38

38/42

 

 

 

 

 

9·82

1·22 (0·26, 5·72)

Allen et al., 19965

58/79

52/70

 

 

 

 

 

43·94

0·96 (0·46, 1·98)

Subtotal (95% CI)

115/145

111/145

 

 

 

 

 

73·25

1·21 (0·69, 2·12)

Test for heterogeneity: chi square = 1·25, df = 2 (P = 0·53)

 

 

 

 

 

 

 

Test for overall effect: Z = 0·65 (P = 0·51)

 

 

 

 

 

 

 

 

Total (95% CI)

148/222

136/191

 

 

 

 

 

100·00

1·21 (0·75, 1·96)

Test for heterogeneity: chi square = 1·72, df = 2 (P = 0·79)

 

 

 

 

 

 

 

Test for overall effect: Z = 0·77 (P = 0·44)

 

 

 

 

 

 

 

 

 

 

0·1

0·2

0·5

1

2

5

10

 

 

 

Favours multifocal

 

Favours monofocal

 

Figure 34.1 Distance visual acuity – less than 6/6 unaided

Study

 

Multifocal

 

Monofocal

SMD (fixed)

Weight

SMD (fixed)

or sub-category

N

Mean (SD)

N

Mean (SD)

 

95% CI

 

%

95% CI

 

 

 

 

 

 

 

 

 

 

 

 

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

 

 

Steinert et al., 199210

32

−6·33 (1·73)

30

−6·37 (1·93)

 

 

 

 

 

18·23

0·02 (−0·48, 0·52)

Javitt and Steinert, 20007

123

−7·78 (1·21)

109

−7·66 (1·36)

 

 

 

 

 

67·95

−0·09 (−0·35, 0·16)

 

 

 

 

 

Leyland et al., 200215

45

0·08 (0·13)

16

0·05 (0·15)

 

 

 

 

 

13·83

0·22 (−0·35, 0·79)

Subtotal (95% CI)

200

 

155

 

 

 

 

 

 

100·00

−0·03 (−0.24, 0·18)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test for heterogeneity: chi square = 1·00, df = 1 (P = 0·61)

 

 

 

 

 

 

 

Test for overall effect: Z = 0·27 (P = 0·79)

 

 

 

 

 

 

 

 

 

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

 

 

Subtotal (95% CI)

0

 

0

 

 

 

 

 

 

 

Not estimable

Test for heterogeneity: not applicable

 

 

 

 

 

 

 

 

 

Test for overall effect: not applicable

 

 

 

 

 

 

 

 

 

Total (95% CI)

200

 

155

 

 

 

 

 

 

100·00

−0·03 (−0·24, 0·18)

 

 

 

 

 

 

 

Test for heterogeneity: chi square = 1·00, df = 2 (P = 0·61)

 

 

 

 

 

 

 

Test for overall effect: Z = 0·27 (P = 0·79)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

−10

−5

0

 

 

5

10

 

 

 

 

 

Favours multifocal

Favours monofocal

 

Figure 34.2 Distance visual acuity – mean unaided

Comment

There was no difference between multifocal and monofocal IOL groups with respect to distance visual acuity. Unaided near vision is critical to the assessment of multifocal efficacy, but was reported in a manner that makes comparison between trials difficult. It is not made

clear in most trials whether the reported print size read has been corrected for reading distance so as to allow a near acuity to be calculated. Only two trials explicitly report near acuity.7,13 A further problem is the use of Jaeger cards. These are not standardised between manufacturers, so that J3 from one trial cannot be

262

 

 

 

 

 

 

Multifocal and monofocal intraocular lenses

Study

Multifocal

Monofocal

 

Peto OR

 

Weight

Peto OR

or sub-category

n/N

n/N

 

95% CI

 

%

95% CI

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

Steinert et al., 199210

12/32

9/30

 

 

 

 

 

12·90

1·39 (0·49, 3·95)

Percival and Setty 19938

9/25

6/25

 

 

 

 

 

9·81

1·75 (0·53, 5·80)

Kamlesh et al., 200111

1/20

5/20

 

 

 

 

 

4·79

0·22 (0·04, 1·20)

Leyland et al., 200212

4/45

2/16

 

 

 

 

 

3·90

0·67 (0·10, 4·48)

Subtotal (95% CI)

26/122

22/91

 

 

 

 

 

31·39

1·03 (0·53, 2·01)

Test for heterogeneity: chi square = 4·45, df = 3 (P = 0·22)

 

 

 

 

 

 

 

Test for overall effect: Z = 0·08 (P = 0·94)

 

 

 

 

 

 

 

 

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

El-Magrahby et al., 19926

9/28

8/33

 

 

 

 

 

11·33

1·47 (0·48, 4·48)

Rossetti et al., 19949

18/38

19/42

 

 

 

 

 

18·39

1·09 (0·45, 2·61)

Allen et al., 19965

39/116

19/101

 

 

 

 

 

38·89

2·12 (1·16, 3·87)

Subtotal (95% CI)

66/182

46/176

 

 

 

 

 

68·61

1·67 (1·06, 2·63)

Test for heterogeneity: chi square = 1·58, df = 2 (P = 0·45)

 

 

 

 

 

 

 

Test for overall effect: Z = 2·22 (P = 0·03)

 

 

 

 

 

 

 

 

Total (95% CI)

92/304

68/267

 

 

 

 

 

100·00

1·43 (0·99, 2·09)

Test for heterogeneity: chi square = 7·42, df = 6 (P = 0·28)

 

 

 

 

 

 

 

Test for overall effect: Z = 1·89 (P = 0·06)

 

 

 

 

 

 

 

 

 

 

0·1

0·2

0·5

1

2

5

10

 

 

 

Favours multifocal

 

Favours monofocal

 

Figure 34.3 Distance visual acuity – less than 6/6 best corrected

Study

 

Multifocal

 

Monofocal

SMD (fixed)

Weight

SMD (fixed)

or sub-category

N

Mean (SD)

N

Mean (SD)

 

95% CI

 

%

95% CI

 

 

 

 

 

 

 

 

 

 

 

 

 

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

 

 

 

Steinert et al., 199210

32

−7·67 (1·25)

30

−8·19 (1·49)

 

 

 

 

 

 

18·02

0·37 (−0·13, 0·88)

Javitt, and Steinert, 20007

123

−8·40 (0·97)

109

−8·46 (0·94)

 

 

 

 

 

 

68·46

0·06 (−0·20, 0·32)

 

 

 

 

 

 

Leyland et al., 200215

45

0.05 (0·10)

16

−0·01 (0·11)

 

 

 

 

 

 

13·52

0·58 (−0·00, 1·16)

Subtotal (95% CI)

200

 

155

 

 

 

 

 

 

 

100·00

0·19 (−0.03, 0·40)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test for heterogeneity: chi square = 3·17, df = 2 (P = 0·21)

 

 

 

 

 

 

 

 

 

Test for overall effect: Z = 1·73 (P = 0·08)

 

 

 

 

 

 

 

 

 

 

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

 

 

 

Subtotal (95% CI)

0

 

0

 

 

 

 

 

 

 

 

Not estimable

Test for heterogeneity: not applicable

 

 

 

 

 

 

 

 

 

 

Test for overall effect: not applicable

 

 

 

 

 

 

 

 

 

 

Total (95% CI)

200

 

155

 

 

 

 

 

 

 

100·00

−0·19 (−0.03, 0·40)

 

 

 

 

 

 

 

 

Test for heterogeneity: chi square = 3·17, df = 2 (P = 0·21)

 

 

 

 

 

 

 

 

 

Test for overall effect: Z = 1·73 (P = 0·08)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

−10

−5

0

 

 

5

10

 

 

 

 

 

Favours multifocal

Favours monofocal

 

Figure 34.4 Distance visual acuity – mean best corrected

assumed to equal J3 from another. Despite these caveats, it is clear that unaided near acuity is improved by the use of multifocal IOLs. It is important to remember, however, that monofocal IOL near acuity can be restored by the use of reading glasses.

Question

Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses in terms of spectacle dependence?

263

Evidence-based Ophthalmology

Study

Multifocal

Monofocal

 

 

 

 

 

 

OR (fixed)

 

 

 

 

 

Weight

OR (fixed)

or sub-category

n/N

n/N

 

 

 

 

 

 

 

 

95% CI

 

 

 

%

95% CI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percival and Setty, 19938

5/25

10/25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15·41

0·38 (0·11, 1·33)

Javitt and Steinert 20007

4/123

37/109

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

73·10

0·07 (0·02, 0·19)

Leyland et al., 200212

31/45

13/16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11·49

0·51 (0·13, 2·08)

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

El-Magrahby et al., 19926

3/23

7/24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5·27

0·36 (0·08, 1·63)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rossetti et al., 19949

5/38

25/42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18·24

0·10 (0·03, 0·32)

Allen et al., 19965

14/116

92/101

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

76·49

0·01 (0·01, 0·03)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0·1

0·2

0·5

1

2

5

10

 

 

 

Favours multifocal

 

 

 

Favours monofocal

 

Figure 34.5 Near visual acuity – less than J3/J4 unaided

Table 34.2 Summary of subjective outcome (“patient satisfaction”) data

Study

Validated measure?

Outcome

Multifocal

Monofocal

 

 

 

 

 

El-Maghraby et al.,

Not measured

19926

 

 

 

 

Steinert et al., 199210

No; standard

Mean satisfaction

1·77 (1·36)

1·35 (0·80)

 

questionnaire

1–7 (1 = best,

 

 

 

 

7 = worst) (SD)

 

 

Percival and Setty,

No; method not

Percentage satisfied

96%

92%

19938

reported

 

 

 

Rossetti et al., 19949

No; method not

Percentage satisfied

68%

78%

 

reported

or highly satisfied

 

 

Allen et al., 19965

No; method not

Overall visual

95%

93%

 

reported

satisfaction good

 

 

Javitt and Steinart,

Yes; TyPE

Mean overall visual

8·4

7·9

20007

questionnaire

satisfaction 0–10

 

 

 

 

(0 = worst, 10 = best)

 

 

Kamlesh et al., 200111

No; standard

Percentage rating

70%

80%

 

questionnaire

vision as good

 

 

Leyland et al., 200212

 

Median overall visual

 

 

 

Yes; TyPE

satisfaction 0–10

 

questionnaire

(0 = worst; 10 = best)

 

 

 

 

 

 

 

The evidence

In all RCTs the majority of multifocal IOL participants still used spectacles for some tasks – usually for reading small print. Freedom from spectacles was, however, more frequent with multifocal than monofocal IOLs in seven trials

(Peto odds ratio for spectacle dependence 0·15, 95% CI 0·11–0·22, Figure 34.6).

Comment

Spectacle independence is more likely to be achieved with use of the multifocal IOL than monofocal IOLs.

264

Multifocal and monofocal intraocular lenses

Study

Multifocal

Monofocal

 

 

 

 

 

 

 

 

 

 

Peto OR

 

 

 

 

 

Weight

Peto OR

or sub-category

n/N

n/N

 

 

 

 

 

 

 

 

 

 

 

95% CI

 

 

 

%

95% CI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Steinert et al., 199210

22/31

25/28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7·77

0·33 (0·09, 1·16)

Percival and Setty, 19938

14/25

23/25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7·87

0·16 (0·05, 0·56)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Javitt and Steinert 20007

84/124

102/109

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30·07

0·20 (0·11, 0·38)

Kamlesh et al., 200111

9/20

19/20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6·90

0·10 (0·03, 0·37)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leyland et al., 200212

32/45

16/16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6·45

0·18 (0·05, 0·73)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subtotal (95% CI)

161/245

185/198

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

59·06

0·19 (0·12, 0·30)

Test for heterogeneity: chi square = 1·78, df = 4 (P = 0·78)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test for overall effect: Z = 7·13 (P < 0·00001)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rossetti et al., 19949

20/38

39/42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12·54

0·13 (0·05, 0·35)

Allen et al., 19965

72/116

97/98

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28·41

0·11 (0·06, 0·21)

Subtotal (95% CI)

92/154

136/140

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40·94

0·11 (0·07, 0·20)

Test for heterogeneity: chi square = 0·07, df = 2 (P = 0·79)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test for overall effect: Z = 7·73 (P < 0·00001)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total (95% CI)

253/399

321/338

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100·00

0·15 (0·11, 0·22)

Test for heterogeneity: chi square = 3·76, df = 6 (P = 0·71)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test for overall effect: Z = 10·42 (P < 0·00001)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0·1

 

0·2

 

0·5

1

2

5

10

 

 

 

Favours multifocal

 

 

 

Favours monofocal

 

Figure 34.6 Spectacle dependence

However, in no trial did more than half of the participants achieve spectacle independence.

Question

Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses for in terms of depth of field?

The evidence

Four trials measured depth of field (the amount of defocus consistent with retention of useful acuity). Depth of field was improved with the multifocal IOL compared to the monofocal. One trial tested acuity with defocus from emmetropia, and reported the proportion achieving better than or equal to 6/12 acuity at each level of defocus. In the trial, 76% and 57% of multifocal and monofocal patients respectively achieved 6/12 with minus 1·25 D defocus, compared with 96% and 4% at minus 2·5 D defocus. Three trials measured the number of dioptres of defocus through which a 6/12 acuity was achieved, across a range of 3–6 dioptres plus or minus from emmetropia. The data were not presented in such a way as to be combined in a metaanalysis. However, each study reported increased depth of field with the multifocal IOL.

Question

Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses in terms of contrast sensitivity and glare?

The evidence

Contrast is the difference between the brightness of an image and its background divided by the total brightness of image plus background. Contrast sensitivity is the inverse of target contrast threshold. Six trials assessed contrast sensitivity (Table 34.3). All reported lower contrast sensitivity with the multifocal IOL, which is consistent with the expected optical effect of the lens.

Three trials objectively assessed glare using the Brightness Acuity Tester. The differences between lenses was not statistically significant. Seven trials reported subjective results and all describe an increased incidence of adverse visual phenomena with the multifocal IOL (Figure 34.7). In those trials that separated glare from haloes, the latter is the more frequently observed. The TyPE questionnaire quantifies the degree of bother from glare, haloes, and rings around lights on a scale of 0–4, where “not at all” scores 0, “a little bit” scores 1, “moderately” scores 2, “quite a bit” scores 3 and “extremely” scores 4. The mean scores (without glasses on) were 1·57 for the multifocal IOL and 0·43 for the monofocal.7 Median

265

Evidence-based Ophthalmology

Table 34.3 Contrast sensitivity (CS) results

Study

Method

Outcome

Multifocal

Monofocal

 

 

 

 

 

El-Magrahby et al., 19926

Not tested

Steinert, 199210

Regan contrast acuity

Acuity (lines read) at

CS lower at all levels.

Statistically

 

charts

96%, 50%, 25% and

2.59 lines (SD 2.01)

significant at 11%

 

 

11% contrast

at 11%

4·37 lines (SD 2.05)

Percival and Setty,

Regan contrast acuity

Acuity (lines read) at

CS lower at all levels

2·1 lines better

19938

charts

96%, 50%, 25% and

(no analysis)

acuity at 11% level

 

 

11% contrast

 

 

Rossetti et al., 19949

Pelli–Robson chart

Mean score (log units)

1·70

1·73

Allen et al., 19965

VCTS chart (6500

Mean of CS at 5

CS 57·9 to 83·9 lower

CS 57·9 to 83·9

 

near, 6000 distance)

spatial frequencies, at

 

higher

 

 

3 light levels (log units)

 

 

Javitt and Steinert 20007

Not tested

Kamlesh et al., 200114

Pelli–Robson chart

Mean CS score

1·38

1·56

 

 

(log units)

 

 

Leyland et al., 200212

Pelli–Robson chart

Mean (SD) CS score

1·66 (0·16)

1·74 (0·15)

 

 

(log units)

 

 

 

 

 

 

 

scores of 1 (multifocal) and 0 (monofocal) were reported in the other study using the TyPE instrument.12

Comment

Contrast sensitivity was lower in participants with the multifocal IOL. The differences were smaller than would be expected, given the division of light between distance and near focus, which may result from post-receptoral visual processing. Whether the reduction in contrast sensitivity induced by the IOL would be clinically significant would depend on the contrast presented by the visual target and the contrast sensitivity of the patient’s retina. No significant differences between IOLs with respect to objective glare were reported. Subjective experience of adverse visual phenomena (glare/halo) was more likely with multifocal IOLS.

Question

Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses in terms of quality of life?

The evidence

The overall visual satisfaction results from the monofocal IOL control groups illustrate the high level of satisfaction with these

lenses. The non-validated multifocal subjective data are inconclusive. Using the TyPE instrument, one study found a small but statistically significant increase in overall visual satisfaction with the multifocal IOL7 (8·4/10 with the multifocal compared to 7·9/10 with the monofocal) and, as expected, a larger beneficial effect with respect to near vision (7·4/10 and 5·3/10). Another study found unaided overall visual satisfaction to be the same in the two IOL groups (median 8/10).12

Only El-Maghraby et al. (1992)6 did not report any subjective assessment. Of the other seven trials, only Javitt and Steinert (2000)7 and Leyland et al. (2002)12 used a validated instrument: the TyPE cataract questionnaire. The data could not be combined for meta-analysis, and are instead presented in Table 34.2.

Comment

Subjective outcomes are fundamental to the evaluation of multifocal IOLs but, like near vision, measurements were flawed in most of the trials. There was no consistent effect on visual satisfaction evident.

Adverse subjective visual phenomena, particularly haloes or rings around lights, were more prevalent and more troublesome in participants with the multifocal IOL. The lack of a consistent drop in patient satisfaction despite the prevalence of these phenomena could be interpreted as evidence that patients do not perceive them as severe.

266

 

 

 

 

 

 

Multifocal and monofocal intraocular lenses

Study

Multifocal

Monofocal

 

Peto OR

 

Weight

Peto OR

or sub-category

n/N

n/N

 

95% CI

 

%

95% CI

01 Refractive IOLs

 

 

 

 

 

 

 

 

 

Percival and Setty, 19938

3/25

0/25

 

 

 

 

 

5·02

8·05 (0·80, 81·12)

Kamlesh et al., 200111

12/20

7/20

 

 

 

 

 

17·86

2·66 (0·78, 9·05)

Subtotal (95% CI)

15/45

7/45

 

 

 

 

 

22·88

3·39 (1·15, 10·01)

Test for heterogeneity: chi square = 0·69, df = 1 (P = 0·41)

 

 

 

 

 

 

 

Test for overall effect: Z = 2·21 (P = 0·03)

 

 

 

 

 

 

 

 

02 Diffractive IOLs

 

 

 

 

 

 

 

 

 

Rossetti et al., 19949

29/38

13/42

 

 

 

 

 

35·17

6·03 (2·52, 14·43)

Allen et al., 19965

21/79

9/70

 

 

 

 

 

41·95

2·33 (1·05, 5·19)

Subtotal (95% CI)

50/117

22/112

 

 

 

 

 

77·12

3·60 (2·00, 6·49)

Test for heterogeneity: chi square = 2·47, df = 1 (P = 0·12)

 

 

 

 

 

 

 

Test for overall effect: Z = 4·26 (P < 0·0001)

 

 

 

 

 

 

 

 

Total (95% CI)

65/162

29/157

 

 

 

 

 

100·00

3·55 (2·11, 5·96)

Test for heterogeneity: chi square = 3·16, df = 3 (P = 0·37)

 

 

 

 

 

 

 

Test for overall effect: Z = 4·79 (P < 0·00001)

 

 

 

 

 

 

 

 

 

 

0·1

0·2

0·5

1

2

5

10

 

Favours multifocal

Favours monofocal

Figure 34.7 Glare/haloes

Discussion

Six of the eight included trials involved participants who had surgery on only one eye.5,6,8–12 Unilateral trials allow measurement of uniocular outcomes such as visual acuity, but are of limited use when attempting to measure the effect of the multifocal intraocular lenses on quality of life, especially where the fellow eye has good vision.

Implications for practice

There is good evidence that use of multifocal intraocular lenses improves near vision without any adverse effect on distance acuity. Spectacle independence is considerably more likely with use of these intraocular lenses when compared to the standard practice of monofocal implantation.

Whether the improvement in unaided near vision and increased incidence of spectacle independence are sufficiently high to outweigh the loss of contrast sensitivity and the experience of haloes is a matter for an individual patient to decide. The final choice for a patient is likely to depend on his or her motivation to be free of spectacles, guided by realistic expectations as to the likelihood of achieving this aim and understanding of the compromises involved.

Implications for research

The optical and visual effects of multifocal intraocular lenses are now well known. Future research on these and similar intraocular lenses should use validated subjective outcome criteria and strive for clarity in reporting of objective outcomes, particularly with regard to near vision. The search for alternative strategies to achieve spectacle independence such as monovision and accommodating intraocular lenses should continue.

References

1.Desai P, Reidy A, Minassian D. The National Cataract Surgery Survey 1997/98. A report of the results of the clinical outcomes. Br J Ophthalmol 1999;83:1336–40.

2.Minassian D, Rosen P, Dart J, Reidy A, Desai P, Sidhu M. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Br J Ophthalmol 2001;85(7): 822–9.

3.Javitt J, Wang F, Trentacost D, Rowe M, Tarantino N. Outcomes of cataract extraction with multifocal intraocular lens implantation.

Ophthalmology 1997;104:589–99.

4.Holladay J, van Dijk H, Lang A, Portney V, Willis T, Sun R, Oksman H. Optical performance of multifocal intraocular lenses. J Cataract Refract Surg 1990;16:413–22.

5.Allen E, Burton R, Webber S et al. Comparison of a diffractive bifocal and a monofocal intraocular lens. J Cataract Refract Surg 1996;22:446–51.

6.El-Maghraby A, Marzouky A, Gazayerli E et al. Multifocal versus

monofocal intraocular lenses. Visual and refractive comparisons.

J Cataract Refract Surg 1992;18:147–52.

267

Evidence-based Ophthalmology

7.Javitt JC, Steinert RF. Cataract extraction with multifocal intraocular lens implantation. A multinational clinical trial evaluating clinical, functional, and quality-of-life outcomes. Ophthalmology 2000;107: 2040–8.

8.Percival SP, Setty SS. Prospectively randomized trial comparing the pseudoaccommodation of the AMO ARRAY multifocal lens and a monofocal lens. J Cataract Refract Surg 1993;19:26–31.

9.Rossetti L, Carraro F, Rovati M, Orzalesi N. Performance of diffractive

multifocal intraocular lenses in extracapsular cataract surgery.

J Cataract Refract Surg 1994; 20:124–8.

10.Steinert RF, Post CT Jr, Brint SF et al. A prospective, randomized, double-masked comparison of a zonal-progressive multifocal

intraocular lens and a monofocal intraocular lens. Ophthalmology 1992;99:853–60.

11.Kamlesh M, Dadeya S, Kaushik S. Contrast sensitivity and depth of focus with aspheric multifocal versus conventional monofocal intraocular lens. Can J Ophthalmol 2001;36:197–201.

12.Leyland M, Langan L, Goolfee F, Lee N, Bloom P. Prospective randomised double-masked trial of bilateral multifocal, bifocal or monofocal intraocular lenses. Eye 2002;16:481–90.

13.Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.

268